Clinical trial
Cisplatin, Irinotecan, and Radiation Therapy in Treating Patients With…
NCT00316862 · Alliance for Clinical Trials in Oncology, Other · Completed
Key facts
| NCT number | NCT00316862 |
|---|---|
| Title | Cisplatin, Irinotecan, and Radiation Therapy in Treating Patients With Esophageal Cancer or Gastroesophageal Junction Cancer That Can Be Removed By Surgery |
| Official title | A Phase II Trial of Preoperative Irinotecan, Cisplatin and Radiation in Esophageal Cancer |
| Lead sponsor | Alliance for Clinical Trials in Oncology, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Esophageal Cancer |
| Intervention type | Drug, Procedure, Radiation |
| Interventions | cisplatin, irinotecan hydrochloride, therapeutic conventional surgery, radiation therapy |
| Enrollment | 82 |
| Start date | Feb 1, 2006 |
| Primary completion | Dec 1, 2012 |
| Completion | Oct 15, 2014 |
| First posted | Apr 21, 2006 |
| Last update posted | May 8, 2018 |
| Countries | United States |
At a glance
- 10–99 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: